|
AVDL | Avadel Pharmaceuticals Plc |
|
|
AVDL | Avadel Pharmaceuticals Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.08 |
| Leverage | 52.82% |
| Market Cap | $ 926.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -72.0m |
| Margin | -52.53% |
Avadel Pharmaceuticals plc is a biopharmaceutical company in the United States. The company is headquartered in Dublin, Ireland.